Drug Shortage Report for MAR-RISPERIDONE
Report ID | 134015 |
Drug Identification Number | 02371812 |
Brand name | MAR-RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 4MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 Tablet |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-02-16 |
Actual start date | 2021-02-16 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-02-17 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2021-02-17 | English | Compare |
v2 | 2021-02-12 | French | Compare |
v1 | 2021-02-12 | English | Compare |
Showing 1 to 3 of 3